Bone Grafts and Substitutes Market By Type (Allografts, Bone grafts substitutes, Cell based matrices) , By Application (Spinal fusion, Trauma, Joint reconstruction, Dental bone grafting, Craniomaxillofacial) By End user (Hospitals, Specialty clinics, Othe

Bone Grafts and Substitutes Market By Type (Allografts, Bone grafts substitutes, Cell based matrices) , By Application (Spinal fusion, Trauma, Joint reconstruction, Dental bone grafting, Craniomaxillofacial) By End user (Hospitals, Specialty clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The bone grafts and substitutes market size valued for $2,586.30 million in 2021 and is estimated to reach $4,005.26 million by 2031, exhibiting a CAGR of 4.5% from 2022 to 2031.

Bone grafts and substitutes refers to materials and techniques used to replace or regenerate missing or damaged bone tissue. They are typically used when the body's natural healing process is insufficient to repair the damaged bone. These treatments are commonly used in orthopedic and dental surgeries to repair bone fractures, reconstruct bone defects, or enhance bone growth.

The major factors driving the growth of bone grafts and substitutes market include increase in incidence of musculoskeletal disorders, technological advancements for development of advanced bone grafts, and rise in number of sport injuries. There is an increase in the prevalence of musculoskeletal disorders such as osteoarthritis, osteoporosis, and other bone-related conditions, which is driving the demand for bone grafts and substitutes. Bone grafts and substitutes are often used to restore bone mass and promote healing as these conditions can cause bone loss. In addition, there is an increase in the number of surgical procedures performed each year and many of these procedures require the use of bone grafts and substitutes. For instance, spinal fusion surgery which often involves the use of bone grafts or substitutes, is one of the fastest-growing surgical procedures in the U.S. Thus, increase in number of these surgeries results in demand of bone grafts and substitutes and also propels the market expansion.

In addition, advances in technology have led to the development of new bone grafts and substitutes that offer improved biocompatibility, better healing properties and reduced risk of infection or rejection. These advancements are driving the demand for newer, and advanced products. Further, rise in the number of new product launches by key players of the market is anticipated to drive the growth of bone grafts and substitutes market. For instance, in February 2022, Orthofix Medical Inc., launched Opus BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures. Thus, rise in new product launches by key players further drives the growth of the bone grafts and substitutes market.

Furthermore, rise in adoption of strategies by key players of the market cater the demand for bone grafts and substitutes is expected to drive the growth of the market. For instance, in January 2023, Zimmer Biomet Holdings, Inc. acquired Embody, Inc., a privately-held medical device company focused on soft tissue healing. The acquisition includes Embody’s complete portfolio of collagen-based bio integrative solutions to support healing in the most challenging orthopedic soft tissue injuries. Thus, rise in adoption of such strategies is anticipated to drive the growth of the market

However, strict regulatory pathways for approval are the factors that restrain the growth of the market. In addition, absence of favorable reimbursement policies in some countries is expected to hinder the growth of the market. Furthermore, rise in demand for advanced bone grafts, increase in awareness about available bone grafts & substitutes and rise in investments for orthopedics offer lucrative opportunities for the key players of the bone grafts and substitutes market.

The bone grafts and substitutes market is segmented into type, application, end user and region. On the basis of type, the market is categorized into allografts, bone grafts substitute and cell-based matrices. On the basis of application, the market is divided into spinal fusion, trauma, craniomaxillofacial surgery, joint reconstruction and dental bone grafting. On the basis of end user, the market is classified into hospitals, specialty clinics and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global bone grafts and substitutes market are Arthrex, Inc., Johnson & Johnson, Medtronic plc, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Baxter International Inc., Xtant Medical Holdings, Inc., Integra LifeSciences and Orthofix Holdings, Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bone grafts and substitutes market analysis from 2021 to 2031 to identify the prevailing bone grafts and substitutes market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the bone grafts and substitutes market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global bone grafts and substitutes market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Allografts
Machined allografts
Demineralized bone matrix
Bone grafts substitutes
Bone morphogenic proteins (BMP)
Synthetic bone grafts
Cell based matrices

By Application

Spinal fusion
Trauma
Joint reconstruction
Dental bone grafting
Craniomaxillofacial

By End User

Hospitals
Specialty clinics
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Arthrex, Inc
Johnson & Johnson
Medtronic plc
NuVasive, Inc.
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Baxter International Inc.
Xtant Medical Holdings, Inc.
Integra LifeSciences
Orthofix Holdings, Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.